Liver-related mortality among people with hepatitis B and C: Evaluation of definitions based on linked healthcare administrative datasets
- PMID: 36843500
- PMCID: PMC10946991
- DOI: 10.1111/jvh.13824
Liver-related mortality among people with hepatitis B and C: Evaluation of definitions based on linked healthcare administrative datasets
Abstract
Routinely collected and linked healthcare administrative datasets could be used to monitor mortality among people with hepatitis B (HBV) and C (HCV). This study aimed to evaluate the concordance in records of liver-related mortality among people with an HBV or HCV notification, between data on hospitalization for end-stage liver disease (ESLD) and death certificates. In New South Wales, Australia, HBV and HCV notifications (1993-2017) were linked to hospital admissions (2001-2018), all-cause mortality (1993-2018) and cause-specific mortality (1993-2016) datasets. Hospitalization for ESLD was defined as a first-time hospital admission due to decompensated cirrhosis (DC) or hepatocellular carcinoma (HCC). Consistency of liver death definition of mortality following hospitalization for ESLD was compared with two death certificate-based definitions of liver deaths coded among primary and secondary cause-specific mortality data, including ESLD-related (deaths due to DC and HCC) and all-liver deaths (ESLD-related and other liver-related causes). Of 63,292 and 107,430 individuals with an HBV and HCV notification, there were 4478 (2.6%) post-ESLD hospitalization deaths, 5572 (3.3%) death certificate liver disease deaths and 2910 (1.7%) death certificate ESLD deaths. Between 2001 and 2016, among HBV post-ESLD hospitalization deaths (n = 891), 63% (562) had death certificate ESLD recorded, and 83% (741) had death certificate liver disease recorded. Between 2001 and 2016, among HCV post-ESLD hospitalization deaths (n = 3587), 58% (2082) had death certificate ESLD recorded, and 87% (3135) had death certificate liver disease recorded. At least one-third of death certificates with DC and HCC as cause of death had no mention of HBV, HCV or viral hepatitis. Our study identified limitations in estimating and tracking HBV and HCV liver disease mortality using death certificate-based data only. The optimum data for this purpose is either ESLD hospitalisations with vital status information or a combination of these with cause-specific death certificate data.
Keywords: cause-specific ESLD-related; cause-specific liver disease-related; hepatitis B; hepatitis C; mortality trends.
© 2023 The Authors. Journal of Viral Hepatitis published by John Wiley & Sons Ltd.
Conflict of interest statement
GJD has received research support from Gilead Sciences, Merck and AbbVie. GM has received research support from Gilead Sciences and AbbVie. Other authors have no commercial relationships that might pose a conflict of interest in connection with this manuscript.
Figures




Similar articles
-
Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales.JHEP Rep. 2022 Aug 6;4(10):100552. doi: 10.1016/j.jhepr.2022.100552. eCollection 2022 Oct. JHEP Rep. 2022. PMID: 36119722 Free PMC article.
-
Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based study.J Hepatol. 2016 Nov;65(5):879-887. doi: 10.1016/j.jhep.2016.06.025. Epub 2016 Jul 8. J Hepatol. 2016. PMID: 27401548
-
Sensitivity Analysis of Hepatitis B and C Mortality in England Using Data Linkage: Meeting the WHO Elimination Threshold for Mortality.J Viral Hepat. 2025 Apr;32(4):e70016. doi: 10.1111/jvh.70016. J Viral Hepat. 2025. PMID: 40135930 Free PMC article.
-
Hepatitis C and hepatitis B-related mortality in Spain.Eur J Gastroenterol Hepatol. 2009 Aug;21(8):895-901. doi: 10.1097/MEG.0b013e328313139d. Eur J Gastroenterol Hepatol. 2009. PMID: 19357523 Review.
-
Hepatocellular carcinoma: recent trends in Japan.Gastroenterology. 2004 Nov;127(5 Suppl 1):S17-26. doi: 10.1053/j.gastro.2004.09.012. Gastroenterology. 2004. PMID: 15508082 Review.
Cited by
-
Identifying Expert Opinions on the Challenges and Barriers Faced in Implementing Iraq's National Plan for Controlling Hepatitis B.Cureus. 2024 Jun 21;16(6):e62814. doi: 10.7759/cureus.62814. eCollection 2024 Jun. Cureus. 2024. PMID: 39036276 Free PMC article.
-
Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia.Lancet Reg Health West Pac. 2024 Aug 31;51:101185. doi: 10.1016/j.lanwpc.2024.101185. eCollection 2024 Oct. Lancet Reg Health West Pac. 2024. PMID: 39282135 Free PMC article.
References
-
- Mazzali C, Duca P. Use of administrative data in healthcare research. Intern Emerg Med. 2015;10(4):517‐524. - PubMed
-
- Gavrielov‐Yusim N, Friger M. Use of administrative medical databases in population‐based research. J Epidemiol Community Health. 2014;68(3):283‐287. - PubMed
-
- Mikkelsen L, Iburg KM, Adair T, et al. Assessing the quality of cause of death data in six high‐income countries: Australia, Canada, Denmark, Germany, Japan and Switzerland. Int J Public Health. 2020;65(1):17‐28. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical